IQVIA (NYSE: IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles in 2016, IQVIA leverages its extensive healthcare data, domain expertise, and cutting-edge technology (including AI and machine learning) to help clients drive innovation, improve clinical development, enhance commercial effectiveness, and ultimately improve patient outcomes. They connect insights from data with execution speed to accelerate the development and delivery of transformative medicines and healthcare solutions worldwide.
Serves as a major corporate and operational center, housing executive leadership, global administrative functions, and potentially key service line operations like clinical research management and data analytics hubs.
Located in a modern corporate park (Emperor Boulevard), the facility likely features contemporary office design, collaborative workspaces, and technology infrastructure suited for a global data and research organization.
The work culture is generally described as data-driven, collaborative, fast-paced, and focused on innovation within the complex life sciences sector. Emphasis is placed on expertise, global teamwork, and delivering impactful solutions for healthcare challenges.
The Durham headquarters symbolizes the operational integration following the QuintilesIMS merger and acts as a key center for driving the company's strategy in clinical research and advanced analytics.
IQVIA operates in over 100 countries, providing a comprehensive suite of services globally. This includes managing multinational clinical trials, collecting and analyzing healthcare data from diverse international sources, deploying technology platforms worldwide, offering regulatory and compliance consulting adapted to local requirements, and providing commercialization support across major and emerging markets.
4820 Emperor Blvd
Durham
NC
USA
Address: 83 Wooster Heights Rd, Danbury, CT 06810
Key hub for North American corporate operations, strategy, and potentially specific technology or information service lines originating from IMS Health.
Address: 210 Euston Road, London NW1 2DA (Example IQVIA London address, verify specific site)
Central point for serving UK and European clients, coordinating regional clinical trials, navigating European regulatory environments, and housing regional leadership.
Address: 1 Fusionopolis Walk, #06-01 Solaris South Tower, Singapore 138628 (Example IQVIA Singapore address, verify specific site)
Serves as the strategic hub for APAC operations, managing regional client relationships, adapting global solutions to local market needs, and driving growth in the region.
Address: Main Airport Center, Unterschweinstiege 2-14, 60549 Frankfurt am Main (Example IQVIA Frankfurt address, verify specific site)
Key location for serving the DACH region (Germany, Austria, Switzerland) and supporting pan-European projects, leveraging proximity to major pharmaceutical clients in Germany.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, IQVIA' leadership includes:
IQVIA has been backed by several prominent investors over the years, including:
Over the past year, IQVIA has seen targeted leadership appointments, particularly within its major service divisions, reflecting strategic focus on R&D and Technology solutions. Notable transitions include appointments strengthening key business units.
Discover the tools IQVIA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
IQVIA commonly utilizes a standard corporate email format, typically combining the employee's first and last name.
firstname.lastname@iqvia.com
Format
john.doe@iqvia.com
Example
90%
Success rate
IQVIA Press Release • May 7, 2024
IQVIA announced its financial results for the first quarter ending March 31, 2024, reporting revenue and earnings, and providing updates on its business segments (Technology & Analytics Solutions, Research & Development Solutions)....more
Business Wire • April 25, 2024
IQVIA introduced new generative AI features within its OCE platform, aimed at enhancing customer engagement for life sciences companies by improving content generation, personalization, and field team efficiency....more
IQVIA Press Release • February 13, 2024
IQVIA reported financial results for the fourth quarter and full year 2023, highlighting performance across its business segments and providing guidance for 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including IQVIA, are just a search away.